Medtech companies were involved in fewer mergers and acquisitions during 2025’s first quarter but the deals that did occur involved a lot more money. Medtech initial public offerings were down, with only two in the first quarter. Insulin delivery system company Beta Bionics raised $235 million in January and wearable medical technology company Kestra Medical Technologies raised $232 million in March.
Read the full article: Medtech M&A Sees Fewer Deals but More Money in Q1 //
Source: https://www.modernhealthcare.com/digital-health/medtech-ma-deals-q1-2025